|278.08||-2.97||-1.06%||Vol 207.72K||1Y Perf 26.01%|
|Jan 21st, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||326.64||Analyst Rating||Moderate Buy 2.04|
|Potential %||17.46||Finscreener Ranking||★★ 45.67|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 47.71|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★ 57.44|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||61.01||Earnings Rating||Buy|
|Market Cap||16.24B||Earnings Date||9th Feb 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||9th Feb 2022|
|Estimated EPS Next Report||2.82|
|EPS Growth Next 5 Years %||21.10|
|Avg. Weekly Volume||246.30K|
|Avg. Monthly Volume||238.69K|
|Avg. Quarterly Volume||238.52K|
Molina Healthcare Inc (NYSE: MOH) stock closed at 278.08 per share at the end of the most recent trading day (a -1.06% change compared to the prior day closing price) with a volume of 213.76K shares and market capitalization of 16.24B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 10500 people. Molina Healthcare Inc CEO is Joseph M. Zubretsky.
The one-year performance of Molina Healthcare Inc stock is 26.01%, while year-to-date (YTD) performance is -12.58%. MOH stock has a five-year performance of 365.95%. Its 52-week range is between 199.81 and 328.11, which gives MOH stock a 52-week price range ratio of 61.01%
Molina Healthcare Inc currently has a PE ratio of 28.40, a price-to-book (PB) ratio of 6.64, a price-to-sale (PS) ratio of 0.82, a price to cashflow ratio of 5.80, a PEG ratio of 2.32, a ROA of 6.27%, a ROC of 14.92% and a ROE of 25.16%. The company’s profit margin is 2.73%, its EBITDA margin is 4.00%, and its revenue ttm is $20.36 Billion , which makes it $348.66 revenue per share.
Of the last four earnings reports from Molina Healthcare Inc, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $2.82 for the next earnings report. Molina Healthcare Inc’s next earnings report date is 09th Feb 2022.
The consensus rating of Wall Street analysts for Molina Healthcare Inc is Moderate Buy (2.04), with a target price of $326.64, which is +17.46% compared to the current price. The earnings rating for Molina Healthcare Inc stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Molina Healthcare Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Molina Healthcare Inc has a Sell technical analysis rating based on Technical Indicators (ADX : 8.49, ATR14 : 8.21, CCI20 : -92.00, Chaikin Money Flow : -0.18, MACD : -6.81, Money Flow Index : 30.47, ROC : -8.51, RSI : 33.93, STOCH (14,3) : 8.56, STOCH RSI : 0.35, UO : 32.92, Williams %R : -91.44), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Molina Healthcare Inc in the last 12-months were: Dale B. Wolf (Option Excercise at a value of $165 100), Dale B. Wolf (Sold 2 500 shares of value $692 975 ), Daniel Cooperman (Option Excercise at a value of $165 100), Daniel Cooperman (Sold 5 000 shares of value $1 545 650 ), Garrey E. Carruthers (Sold 825 shares of value $183 562 ), Ronna E. Romney (Sold 1 275 shares of value $332 232 ), Thomas L. Tran (Sold 3 196 shares of value $824 658 )
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.